Maintenance bevacizumab-pemetrexed after first-line cisplatinpemetrexed-bevacizumab for advanced nonsquamous nonsmall-cell lung cancer : updated survival analysis of the AVAPERL ( MO22089 ) randomized phase Ⅲ trial .Southwest Oncology Group S0802 : a rand ......